retatrutide parkinson clinical trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Phase III retatrutide study demonstrates

Future studies specifically designed to evaluate hormonal contributions (e.g., estrogenGLP-1 receptor interactions) will be important to mechanistically clarify these sex differences

Brand-name equivalent: Mounjaro / Zepbound Tirzepatide targets two metabolic pathways for enhanced appetite control and metabolic support

The ability of Semaglutide GLP-1, Mounjaro, Wegovy, and Ozempic to maintain long-term weight loss varies due to a number of individual circumstances

The authors would like to acknowledge helpful discussions with Guo Yang, Savitha Ramasamy, and Zhou Weizhuang, and support on compliance and governance from Nurensah Beevi at the Institute for Infocomm Research, A*STAR

Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism

MEDVi highlights that 93% of its patients keep the weight off after initial loss, provided they remain consistent with treatment and follow the care plan